232
Z.-L. Wei et al. / Tetrahedron: Asymmetry 12 (2001) 229–233
3.2.1. (S)-3-Hydroxy-2,2-di(prop-2-ynyl)cyclohexanone
7. White solid, mp 104−106°C; 96%, [h]2D0 −3.5 (c 2.0,
CHCl3). IR (KBr): wmax 3450, 3300, 2950, 1700, 1430,
1350, 1280, 1210, 1130, 1070, 1000, 945, 640, 560 cm−1.
1H NMR (300 MHz, CDCl3): l 4.18 (dd, 1H, J=6.2,
3.0 Hz), 2.80−2.50 (m, 5H), 2.50−2.30 (m, 2H), 2.10−
1.90 (m, 4H), 1.85−1.75 (m, 1H), 1.75−1.60 (m, 1H).
13C NMR (75 MHz, CDCl3): l 209.47, 79.85, 79.55,
73.87, 72.08, 71.81, 56.16, 37.84, 28.32, 22.92, 20.56,
19.97. Anal. calcd for C12H14O2: C, 75.76; H, 7.42.
Found: C, 75.69; H, 7.48.
7.52−7.38 (m, 5H), 5.53 (t, 1H, J=3.5 Hz), 3.51 (s, 3H),
2.86 (dd, 1H, J=7.0, 2.6 Hz), 2.75 (dd, 1H, J=7.5, 2.6
Hz), 2.60−2.46 (m, 2H), 2.38−2.29 (m, 2H), 2.18−2.03
(m, 4H), 1.85−1.77 (m, 1H), 1.70−1.60 (m, 1H). 13C
NMR (100 MHz, CDCl3): l 206.9, 165.7, 131.8, 129.9,
128.6, 127.5, 79.1, 78.2, 77.5, 77.3, 72.9, 72.7, 55.4, 54.1,
37.7, 24.9, 23.4, 20.6, 20.4.
3.4. Determination of the configuration of the ketol 8
To the solution of optically pure ketol 8 (20 mg, 0.1
mmol), obtained from baker’s yeast reduction of 3 in
methylene chloride (1 mL), and pyridine (0.5 mL) at
0°C was added (+)-camphor-10-sulfonyl chloride (120
mg, 0.5 mmol). The mixture was warmed to room
temperature and stirred for a day. After that the mix-
ture was diluted with ethyl acetate and the organic layer
was washed with brine, dried, filtered, and condensed.
Purification of the residue by chromatography with
petroleum ether–ethyl acetate (10:1) provided the corre-
sponding (+)-camphorsulfonates 12 (35 mg, 83%) as a
white solid: mp 90−91°C. [h]2D0 +43.6 (c 0.2, CHCl3). IR
(KBr): wmax 2973, 1738, 1709, 1446, 1339, 1175, 895, 870
3.2.2. (S)-2,2-Diallyl-3-hydroxycyclohexanone 8. White
solid, e.e.: 98.4%, [h]2D0 +11 (c 2.2, CHCl3). IR (KBr):
wmax 3450, 2940, 1685, 1640, 1340, 1275, 1215, 1110,
1
980, 920 cm−1. H NMR (300 MHz, CDCl3): l 5.70−
5.50 (m, 2H), 5.10−4.90 (m, 4H), 3.92 (dd, 1H, J=7.1,
3.1 Hz), 2.50−2.20 (m, 7H), 2.10−1.75 (m, 3H), 1.70−
1.50 (m, 1H). 13C NMR (75 MHz, CDCl3): l 212.39,
133.93, 133.47, 118.34, 118.06, 73.96, 57.46, 38.25,
36.82, 34.07, 28.23, 20.48. Anal. calcd for C12H18O2: C,
74.19; H, 9.34. Found: C, 73.88; H, 9.66. The enan-
tiomeric excess was determined by HPLC analysis using
Chiralpak AD column (0.46×25 cm) detected at UV
214 nm; eluent: hexane–2-propanol (9:1); rate of flow:
0.7 mL/min.
1
cm−1. H NMR (300 MHz, CDCl3): l 5.77−5.57 (m,
2H), 5.19−5.13 (m, 4H), 5.06 (dd, 1H, J=6.2, 3.7 Hz),
3.63 and 3.03 (AB, 2H, J=14.9 Hz), 2.60−2.27 (m, 9H),
2.14−1.93 (m, 4H), 1.88−1.75 (m, 1H), 1.68−1.61 (m,
2H), 1.49−1.43 (m, 1H), 1.13 (s, 3H), 0.88 (s, 3H). Anal.
calcd for C22H32O5S: C, 64.68; H, 7.89; S, 7.85. Found:
C, 64.66; H, 7.90; S, 8.07.
3.2.3.
3-[1-(2-Carboxylethyl)-2,6-dioxocyclohexyl]-
propionic acid methyl ester 10. White solid, mp 87−
89°C. IR (KBr): wmax 3400, 2900 (br), 1710 (br), 1450,
1
1410, 1330, 1290, 1210, 1170, 1030, 995, 910 cm−1. H
NMR (300 MHz, CDCl3): l 8.82 (br s, 1H), 3.70 (s,
3H), 2.90−2.50 (m, 4H), 2.50−2.20 (m, 4H), 2.20−1.90
(m, 6H). MS m/z (rel. intensity): 271 ([M+1]+, 12.7),
253 (33.9), 224 (45.2), 221 (100), 192 (54.7), 179 (44.2),
164 (38.2), 151 (52.4), 137 (45.2), 123 (38.5), 55 (78.3).
Anal. calcd for C13H18O6: C, 57.77; H, 6.71. Found: C,
57.45; H, 6.67.
Crystals of 12 suitable for X-ray analysis were cultured
from methylene chloride–petroleum ether. Data were
collected on a Rigaku AFC7R diffractometer using the
ꢀ−2q scan technique at 293 K. The intensities were
corrected for Lorentz-polarization effects. The structure
was solved by direct methods13 and expanded using
Fourier techniques.14 The non-hydrogen atoms were
refined anisotropically. Hydrogen atoms were included
but not refined. All calculations were performed using
the teXsan crystallographic software package.15 Crystal
data: colorless prismatic monoclinic crystal (0.20×0.20×
3.3. Determination of the absolute configuration of
ketol 7
,
To a stirred solution of 7 (15 mg, 0.14 mmol) in
methylene chloride (2 mL) was added dicyclohexylcar-
bodiimide (80 mg), 4-dimethylaminopyridine (3 mg),
and (R)-(+)-a-methoxy-a-(trifluoromethyl)phenyl acetic
acid (40 mg, 0.21 mmol). The mixture was stirred at
room temperature for 2 days, then filtered and the
filtrate was diluted with ethyl acetate (20 mL). The
organic phase was washed with saturated aqueous
sodium bicarbonate and brine, dried, filtered, and con-
densed under reduced pressure. The residue was
purified by chromatography over silica gel with
petroleum ether–ethyl acetate (7:1) to provide (R)-11
0.30 mm) in space group P21 (c4); a=11.204(2) A,
,
,
b=7.9105(9) A, c=13.093(3) A, i=111.86(1)°, V=
3
1077.0(3) A ; Z=2; Dcalcd=1.260 g cm−3; F(000)=
,
440.00; Mo Kh (u=0.71069 A), v=1.79 cm−1;
reflections measured=2769, unique reflections=2641
(Rint=0.015); observations [I>2|(I)]=2236; parame-
ters=253; goodness-of-fit=1.68; R=0.041, Rw=0.047.
,
Acknowledgements
1
(30 mg, 94%). H NMR (300 MHz, CDCl3): l 7.53−
The authors are grateful to the National Natural Sci-
ence Foundation of China (Grant No. 39770020) for
financial support.
7.39 (m, 5H), 5.60 (dd, 1H, J=5.2, 3.0 Hz), 3.51 (s,
3H), 2.86 (dd, 1H, J=6.9, 2.5 Hz), 2.71 (dd, 1H,
J=7.5, 2.6 Hz), 2.63−2.37 (m, 2H), 2.29−2.16 (m, 2H),
2.13−2.03 (m, 4H), 1.94−1.80 (m, 2H). MS m/z (rel.
intensity): 407 ([M+1]+, 0.7), 406 (M+, 0.4), 189 (100).
References
(S)-11 was similarly prepared according to the above
1. For reviews, see: (a) Csuk, R.; Glanzer, B. I. Chem. Rev.
1991, 91, 49. (b) Sevi, S. Synthesis 1990, 1. (c) Santaniello,
1
procedure, yield 90%. H NMR (300 MHz, CDCl3): l